{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:00:19Z","timestamp":1787320819413,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.chroma.2025.465769","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:54:26Z","timestamp":1739472866000},"page":"465769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative analysis of impurity profiles in rifampicin capsules with different crystal forms using LC-MS\/MS"],"prefix":"10.1016","volume":"1746","author":[{"given":"Yun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Tong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozuo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5664-9509","authenticated-orcid":false,"given":"Hian Kee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3372-7412","authenticated-orcid":false,"given":"Hai-Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.465769_bib0001","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1093\/clinids\/5.Supplement_3.S407","article-title":"Rifampin: mechanisms of action and resistance","volume":"5","author":"Wehrli","year":"1983","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chroma.2025.465769_bib0002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA","volume":"104","author":"Campbell","year":"2001","journal-title":"Polymerase. Cell."},{"key":"10.1016\/j.chroma.2025.465769_bib0003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jiac.2016.02.011","article-title":"Investigation on rifampicin administration from the standpoint of pharmacokinetics\/pharmacodynamics in a neutropenic murine thigh infection model","volume":"22","author":"Hirai","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.chroma.2025.465769_bib0004","first-page":"e90569","article-title":"Correlation between genotypic and phenotypic testing for resistance to Rifampin in mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results","author":"Jagielski","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chroma.2025.465769_bib0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2018.07.011","article-title":"Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment","volume":"548","author":"Khadka","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chroma.2025.465769_bib0006","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1038\/s41598-020-65308-2","article-title":"Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2025.465769_bib0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"RifamycinMode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chroma.2025.465769_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"Forrest","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chroma.2025.465769_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijbiomac.2019.01.034","article-title":"Depicting the DNA binding and photo-nuclease ability of anti-mycobacterial drug rifampicin: a biophysical and molecular docking perspective","volume":"127","author":"Chakraborty","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.chroma.2025.465769_bib0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/jm00220a008","article-title":"2-(2-Aminoethylamino)-1,2-diphenylethanol derivatives, a new class of topical antiinflammatory agents","volume":"20","author":"Fryer","year":"1977","journal-title":"Med. Chem."},{"key":"10.1016\/j.chroma.2025.465769_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s41981-018-0017-2","article-title":"Continuous preparation for rifampicin","volume":"8","author":"Li","year":"2018","journal-title":"J. Flow Chem."},{"key":"10.1016\/j.chroma.2025.465769_bib0012","doi-asserted-by":"crossref","first-page":"taad134","DOI":"10.1093\/jtm\/taad134","article-title":"Clinical management of anti-tuberculosis related cutaneous adverse drug reactions based on reintroduction","volume":"30","author":"Beytout","year":"2023","journal-title":"J. Travel Med."},{"key":"10.1016\/j.chroma.2025.465769_bib0013","article-title":"IFN-\u03b3 ELISpot in severe cutaneous adverse reactions to first-line antituberculosis drugs in an HIV endemic setting","volume":"142","author":"Porter","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chroma.2025.465769_bib0014","doi-asserted-by":"crossref","first-page":"11275","DOI":"10.1038\/s41598-023-38394-1","article-title":"Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2025.465769_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011867","article-title":"Amoxicillin\/clavulanate in combination with rifampicin\/clarithromycin is bactericidal against mycobacterium ulcerans","volume":"18","author":"S\u00e1ez-L\u00f3pez","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chroma.2025.465769_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01243-18","article-title":"Evolution of rifampin resistance in Escherichia coli and mycobacterium smegmatis due to substandard drugs","volume":"63","author":"Weinstein","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chroma.2025.465769_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115650","article-title":"New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS\/MS","volume":"235","author":"Kara\u017aniewicz-\u0141ada","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465769_bib0018","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.xphs.2017.10.004","article-title":"In situ monitoring and modeling of the solution-mediated polymorphic transformation of rifampicin: from form II to form I","volume":"107","author":"Guo","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2025.465769_bib0019","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.3390\/ijms23169013","article-title":"The relevance of crystal forms in the pharmaceutical field: sword of Damocles or innovation tools?","author":"Braga","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2025.465769_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jpba.2015.06.012","article-title":"Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography","volume":"114","author":"Li","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465769_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chroma.2015.02.063","article-title":"Peak distortions arising from large-volume injections in supercritical fluid chromatography","volume":"1392","author":"Dai","year":"2015","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2025.465769_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116459","article-title":"Identification and quantitative analysis of genotoxic impurities in rifampicin: development and validation of a targeted LC-MS\/MS method for 1-amino-4-methylpiperazine","volume":"252","author":"Jiang","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.chroma.2025.465769_bib0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/01483917908060069","article-title":"High performance liquid chromatographic analysis of rifampin and related impurities in pharmaceutical formulations","volume":"2","author":"Graham","year":"1979","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.chroma.2025.465769_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300627","article-title":"Environmentally friendly degradation and detoxification of rifampicin by a bacterial laccase and hydrogen peroxide","volume":"25","author":"Dur\u00e3o","year":"2024","journal-title":"ChemBioChem"},{"key":"10.1016\/j.chroma.2025.465769_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.109869","article-title":"Profiling of 3-formyl rifamycin (3-FR) from sintered fixed dose combinations (SDC) of rifampicin and isoniazid by using RP-HPLC, LC-ESI-QTOF and UPLC\/MS\/MS","author":"Karanwad","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.chroma.2025.465769_bib0026","unstructured":"European Medicines Agency. Guideline on setting specifications for related impurities in antibiotics. June 30, 2012. Accessed February 09, 2025. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/adopted-guideline-setting-specifications-related-impurities-antibiotics_en.pdf."},{"key":"10.1016\/j.chroma.2025.465769_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/435129","article-title":"Analytical quality by design approach to test method development and validation in drug substance manufacturing","volume":"2015","author":"Raman","year":"2015","journal-title":"J. Chem."},{"key":"10.1016\/j.chroma.2025.465769_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464897","article-title":"Insight into soft chemometric computational learning for modelling oily-wastewater separation efficiency and permeate flux of polypyrrole-decorated ceramic-polymeric membranes","volume":"1725","author":"Baig","year":"2024","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2025.465769_bib0029","first-page":"494","article-title":"Integrated computer-aided formulation design: a case study of andrographolide\/cyclodextrin ternary formulation","volume":"16","author":"Gao","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2025.465769_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464045","article-title":"A compounds annotation strategy using targeted molecular networking for offline two-dimensional liquid chromatography-mass spectrometry analysis: yupingfeng as a case study","volume":"1702","author":"Zhu","year":"2023","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.chroma.2025.465769_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463583","article-title":"Using multiple heart-cutting valves and stop-flow operation to enable variable second dimension gradient times in online comprehensive two-dimensional liquid chromatography","volume":"1685","author":"Nell","year":"2022","journal-title":"J. Chromatogr. A."},{"issue":"1\u20132","key":"10.1016\/j.chroma.2025.465769_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0021-9673(99)01120-6","article-title":"Adsorption\/partition model of liquid chromatography for chemically bonded stationary phases of the aliphatic cyano, reversed-phase C8 and reversed-phase C18 types","volume":"869","author":"Kaczmarski","year":"2000","journal-title":"J. Chromatogr. A."},{"issue":"16","key":"10.1016\/j.chroma.2025.465769_bib0033","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.chroma.2011.02.012","article-title":"Mobile phase effects in reversed-phase liquid chromatography: a comparison of acetonitrile\/water and methanol\/water solvents as studied by Molecular simulation","volume":"1218","author":"Rafferty","year":"2011","journal-title":"J. Chromatogr. A."},{"issue":"20","key":"10.1016\/j.chroma.2025.465769_bib0034","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1021\/acs.analchem.2c00325","article-title":"Ultrahigh-performance supercritical fluid chromatography and detection of multiple biogenic amines in gentamicin sulfate: method development using computer-assisted modeling","volume":"94","author":"Duan","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465769_bib0035","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cej.2016.07.029","article-title":"Identification of intermediates and transformation pathways derived from photocatalytic degradation of five antibiotics on ZnIn2S4","volume":"304","author":"Gao","year":"2016","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.chroma.2025.465769_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2020.121617","article-title":"Adsorption and catalytic reduction of rifampicin in wastewaters using hybrid rGO@Fe\/Pd nanoparticles","volume":"264","author":"Xu","year":"2020","journal-title":"J. Clean. Prod"},{"key":"10.1016\/j.chroma.2025.465769_bib0037","doi-asserted-by":"crossref","first-page":"14030","DOI":"10.1038\/s41598-023-41119-z","article-title":"Green synthesis of copper oxide nanoparticles and its efficiency in degradation of rifampicin antibiotic","volume":"13","author":"Nzilu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2025.465769_bib0038","doi-asserted-by":"crossref","first-page":"40099","DOI":"10.1021\/acsomega.3c02652","article-title":"Rh-In2o3 nanoparticles for efficient photocatalytic degradation of rifampin","volume":"8","author":"Tang","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.chroma.2025.465769_bib0039","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/toxsci\/kft235","article-title":"Tanguay, multidimensional In vivo hazard assessment using Zebrafish","volume":"137","author":"Truong","year":"2014","journal-title":"Toxicol. Sci"},{"key":"10.1016\/j.chroma.2025.465769_bib0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.yrtph.2014.05.018","article-title":"OECD validation study to assess intra- and inter-laboratory reproducibility of the zebrafish embryo toxicity test for acute aquatic toxicity testing","volume":"69","author":"Busquet","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T07:31:47Z","timestamp":1741246307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0021967325001177"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465769","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of impurity profiles in rifampicin capsules with different crystal forms using LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"465769"}}